butamirate, Lidocaine | Proctosan rectal suppositories 10 pcs.

Release form

Rectal suppositories.

Packing

10 pcs.

Pharmacological action of

Bufexamak (a derivative of aryl acetic acid) has an anti-inflammatory effect. Bismuth subgallate has an astringent effect and promotes wound healing. Titanium dioxide has an astringent and drying effect, promotes wound healing. Lidocaine hydrochloride hydrate is a local anesthetic.

Contraindications

Hypersensitivity to the drug, specific inflammatory processes (syphilis, tuberculosis), childhood, pregnancy, lactation.

Special instructions

In the absence of effect, as well as the appearance of discomfort and other side effects, discontinue use of the drug and consult a doctor. Long-term use of the drug is not recommended. If long-term treatment is necessary, medications that do not contain local anesthetics should be used. With the simultaneous use of Proctosan® and a condom, a decrease in the strength of condoms may be noted, which reduces their reliability.

Composition

1 suppository contains: bufexamak - 250 mg, bismuth subgallate - 100 mg, titanium dioxide - 100 mg, lidocaine hydrochloride hydrate - 10 mg Excipient: solid fat - 1540 mg.

Dosage and administration

Used rectally, 1 suppository 1-2 times a day, if possible after bowel movement. Continued use of the drug after the abatement of acute events for 8 to 10 days is recommended.

Side effects

Hypersensitivity reactions to the components of the drug are possible (burning, itching, redness of the skin of the perianal zone, edema, the formation of vesicles, flakes, etc.).

Storage conditions

At a temperature not exceeding 25 РC.

Keep out of the reach of children.

Expiration

5 years. Do not use the drug after the expiration date, indicated on the package.

Active ingredient

Bufesamak, Bismuth subgal titanium dioxide, Lidocaine

Terms and conditions

without prescription

Appointment

Vzrosl m

Indications

Hemorroy, Эkzema

Shtada Artsnaymittely AG, Germany